Acrivastine and pseudoephedrine and Linagliptin and Metformin Extended-Release Tablets
Determining the interaction of Acrivastine and pseudoephedrine and Linagliptin and Metformin Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: acrivastine / pseudoephedrine
Brand name: Semprex-D
Synonyms: Acrivastine and Pseudoephedrine
Generic Name: linagliptin / metformin
Brand name: Jentadueto, Jentadueto XR
Synonyms: Linagliptin and metformin, Linagliptin and Metformin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Acrivastine and pseudoephedrine-Linagliptin and Metformin Tablets
- Acrivastine and pseudoephedrine-Lincocin
- Acrivastine and pseudoephedrine-Lincomycin
- Acrivastine and pseudoephedrine-Lincomycin Hydrochloride
- Acrivastine and pseudoephedrine-Lincomycin Injection
- Acrivastine and pseudoephedrine-Lincomycin Oral, Injection
- Linagliptin and Metformin Extended-Release Tablets-Actamin
- Linagliptin and Metformin Extended-Release Tablets-Actamin Maximum Strength
- Linagliptin and Metformin Extended-Release Tablets-Actemra
- Linagliptin and Metformin Extended-Release Tablets-Actemra (Tocilizumab (Intravenous))
- Linagliptin and Metformin Extended-Release Tablets-Actemra (Tocilizumab Auto-Injectors)
- Linagliptin and Metformin Extended-Release Tablets-Actemra (Tocilizumab Prefilled Syringes)